©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 115830
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115830
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115830
Table 3 Multivariate analysis identified the risk factors for small intestinal mucosal injury in patients using nonsteroidal anti-inflammatory drugs, n (%)
| Characteristic | Univariate analysis | Multivariate analysis | ||
| OR (95%CI) | P value | OR (95%CI) | P value | |
| Age | 1.045 (1.010-1.082) | 0.011 | 1.043 (1.003-1.084) | 0.033 |
| Smoking | 2.126 (1.139-3.968) | 0.018 | 2.352 (1.088-5.086) | 0.030 |
| BMI | 1.174 (1.035-1.331) | 0.013 | 1.176 (1.019-1.358) | 0.026 |
| PPI | 2.009 (1.089-3.705) | 0.025 | 2.099 (1.003-4.390) | 0.049 |
| TG | 2.279 (1.232-4.215) | 0.009 | 2.427 (1.196-4.924) | 0.014 |
| LDL | 1.557 (1.107-2.188) | 0.011 | 1.606 (1.089-2.367) | 0.017 |
- Citation: Zhao NH, Zhao LR, Yao J, Niu LY, Yang LJ, Lin YJ, Liu M. Development and validation of a risk prediction model for small intestinal mucosal injury in nonsteroidal anti-inflammatory drug users. World J Gastrointest Surg 2026; 18(2): 115830
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/115830.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.115830